Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Comparison of Nexavar with a placebo as maintenance therapy for patients with advanced
Ovarian or primary Peritoneal cancers in complete remission following surgery and one regimen
of chemotherapy.